GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
79 hedge funds and large institutions have $579M invested in GenMark Diagnostics, Inc in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 10 closing their positions.
52% more capital invested
Capital invested by funds: $380M → $579M (+$199M)
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
4% less funds holding
Funds holding: 82 → 79 (-3)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$9.39M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.01M |
| 3 |
JP Morgan Chase
New York
|
+$4.56M |
| 4 |
VAM
Visium Asset Management
New York
|
+$2.44M |
| 5 |
JG
Jefferies Group
New York
|
+$2.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$15.7M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$6.68M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.4M |
| 4 |
GC
Gruss & Co
West Palm Beach,
Florida
|
-$1.17M |
| 5 |
Asset Management One
Tokyo,
Japan
|
-$1.15M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
76
Glenmede Trust
Philadelphia,
Pennsylvania
| $13K | – | – | – |
|
|
TDC
77
Thompson Davis & Co
Richmond,
Virginia
| $7K | – | – | – |
|
78
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
79
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $379 | -$3.12K | -279 | -1% |
|
|
JHIU
80
Janus Henderson Investors US
Denver,
Colorado
| – | -$6.68M | -744,887 | Closed |
|
|
GC
81
Gruss & Co
West Palm Beach,
Florida
| – | -$1.17M | -130,000 | Closed |
|
|
82
Asset Management One
Tokyo,
Japan
| – | -$1.15M | -126,790 | Closed |
|
|
DC
83
Deere & Company
Moline,
Illinois
| – | -$202K | -22,488 | Closed |
|
|
ARTA
84
A.R.T. Advisors
New York
| – | -$195K | -21,799 | Closed |
|
85
ProShare Advisors
Bethesda,
Maryland
| – | -$148K | -16,532 | Closed |
|
86
Principal Financial Group
Des Moines,
Iowa
| – | -$124K | -13,862 | Closed |
|
87
AQR Capital Management
Greenwich,
Connecticut
| – | -$108K | -12,094 | Closed |
|
88
BNP Paribas Financial Markets
Paris,
France
| – | -$24.6K | -2,738 | Closed |
|
89
Ameriprise
Minneapolis,
Minnesota
| – | -$3K | -331 | Closed |
|
GNMK Hedge Fund Activity: Q4 2014 in Review
79 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2014, worth a combined $579M — up 52% from $380M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GNMK and 9 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 27 added.
The largest buyer was Camber Capital Management, adding an estimated $9.39M. The largest seller was Massachusetts Financial Services, cutting an estimated $15.7M.
- 79 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2014, down from 82 in Q3 2014.
- Funds reported $579M of GenMark Diagnostics, Inc stock for Q4 2014, up 52% quarter-over-quarter.
- 9 funds opened new GenMark Diagnostics, Inc positions in Q4 2014 and 10 closed out, a net change of -1 holder.
- The largest GenMark Diagnostics, Inc buyer in Q4 2014 was Camber Capital Management, an estimated $9.39M added.
- The largest GenMark Diagnostics, Inc seller in Q4 2014 was Massachusetts Financial Services, an estimated $15.7M sold.
Based on aggregated 13F filings for Q4 2014.